Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2209 ARTÍCULOS , VIENDO DEL 271 AL 285

Glycopolymers as emerging modulators of Amyloid-β aggregation: structure-activity relationships and therapeutic potential

Cardoso E, Serra AC, Coelho JFJ, Pereira P.

Carbohydr Polym. 2026 Sep 15;388:125572. doi: 10.1016/j.carbpol.2026.125572. Epub 2026 Jun 21.

Application of the Allen Human Brain Atlas in Alzheimer's disease and Parkinson's disease

Xiao Y, Wang S, Hou Y, Shang H.

Transl Neurodegener. 2026 Jul 23;15(1):33. doi: 10.1186/s40035-026-00566-0.

APP/Aβ Signaling Orchestrates Reactive Astrocyte Networks in Alzheimer's Disease

Jauregui GV, Coomes S, Emmett E, Thatcher A, Oyelakin N, Čarna M, Zelinkova J, Novotny JS, Polakova N, Kuruvilla T, Zorec R, Verkhratsky A, Parpura V, Morgan D, Moya KL, Limback-Stokin C, Stokin GB.

J Neurochem. 2026 Jul;170(7):e70526. doi: 10.1111/jnc.70526.

Sustaining Drug Discovery Amid the Limits of Alzheimer's Disease Immunotherapies

McDiarmid A.

eNeuro. 2026 Jul 24;13(7):ENEURO.0112-26.2026. doi: 10.1523/ENEURO.0112-26.2026. Print 2026 Jul.

Theoretical and practical challenges for capturing reserve and resilience in aging and Alzheimer's disease: A narrative review

Ourry V, Wagner M, Groot C, Boyle R, Vogel JW, Bartrés-Faz D, Villeneuve S.

Alzheimers Dement. 2026 Jul;22(7):e71664. doi: 10.1002/alz.71664.

Association between Alzheimer's disease and MHC-I antigen processing and presentation pathway: a narrative review

Wang C, Yun Q, Zhang Z, Zhao H, Lin F, Cao H.

Front Immunol. 2026 Jul 10;17:1877167. doi: 10.3389/fimmu.2026.1877167. eCollection 2026.

Targeting the NLRP3 inflammasome in Alzheimer's disease: Mechanistic insights and therapeutic advances

Lian W, Zhou F, Tong Z, Xia C, Yan Y, He J, Xu J, Zhang W.

Ageing Res Rev. 2026 Oct;121:103273. doi: 10.1016/j.arr.2026.103273. Epub 2026 Jul 25.

Modulating Stress Granules via HDAC6 Inhibition: A Promising Strategy against Alzheimer's Disease

Jagaselvan E, Mondal P, Zhang C.

ACS Chem Neurosci. 2026 Aug 5;17(15):2771-2774. doi: 10.1021/acschemneuro.6c00264.

Microglia in Alzheimer's Disease: From Homeostatic Guardians to Multifaceted Drivers of Neuropathology

Ma L, Zhao Y, Cai C, Liu Q, Hu X, Wang L.

Cells. 2026 Jul 18;15(14):1291. doi: 10.3390/cells15141291.

Targeting Histone Deacetylase 2 in Alzheimer's Disease: From Molecular Insights to Epigenetic Therapeutic Opportunities

Anand A, Sania A, Singh SK, Bajad N.

Mol Neurobiol. 2026 Jul 27;63(1):793. doi: 10.1007/s12035-026-06078-2.

Network Biology of Alzheimer's Disease and Related Neurodegenerative Disorders: Molecular Mechanisms and Therapeutic Strategies

Wali Z, Neha, Shahwan M, Dinislam K, Shamsi A, Anwar S.

Biomolecules. 2026 Jun 24;16(7):944. doi: 10.3390/biom16070944.

Synaptic vs. Non-Synaptic Glycine Receptors: Physiological Role and Implications in Alzheimer's Disease Pathology

Kiss E, Kirsch J, Kins S, Kuhse J.

Int J Mol Sci. 2026 Jul 15;27(14):6306. doi: 10.3390/ijms27146306.

Special Issue "Molecular Insight into Alzheimer's Disease"

Malaplate C, Oster T.

Int J Mol Sci. 2026 Jul 18;27(14):6385. doi: 10.3390/ijms27146385.

Cholesterol at the Center of Alzheimer's Disease: A Unifying Hypothesis on the Pathogenic Mechanism

Zhu BT.

Molecules. 2026 Jul 9;31(14):2418. doi: 10.3390/molecules31142418.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias